Federal Trade Commission Chairman Jon Leibowitz, Commissioner Pamela Jones Harbour, and Commissioner William E. Kovacic have issued a joint statement in response to the announcement by Endocare, Inc., that it has terminated its merger agreement with Galil Medical Ltd. during the agency’s ongoing investigation.
The statement can be found on the agency’s Web site and as a link to this press release. Commissioner J. Thomas Rosch has also released a statement in response to the announcement by Endocare. The statements are the only publicly available documents regarding this matter.
Copies of the documents mentioned in this release are available from the FTC’s Web site at http://www.ftc.gov and from the FTC’s Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, DC 20580. Call toll-free: 1-877-FTC-HELP.
- Media Contact:
- Office of Public Affairs